COMP <GO>
ULS vs JNJ // ENTERPRISE SCALE & MARKET CAP
UL Solutions Inc. (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: ULS 5
— JNJ 7
▲ ENTERPRISE SCALE & MARKET CAP LEADER: JNJ
LAST: $74.76 (-0.93%) • MKT CAP: $15.24B
market-cap
$15.24B
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
market-cap
$662.49B
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ULS VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ULS | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 49.50% | 67.90% | -18.40 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 28.30% | 25.50% | +2.80 | ULS | /roic <GO> |
| EV/EBITDA & P/E Valuation | 22.4x | 18.5x | +3.90 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 2.65% | 2.97% | -0.32 | JNJ | /fcf-yield <GO> |
| Operating Margin | 17.10% | 34.70% | -17.60 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 10.60% | 28.50% | -17.90 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 6.40% | 6.00% | +0.40 | ULS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.68% | 0.00% | +0.68 | ULS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 7.58 | 5.59 | +1.99 | ULS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 7.20% | 0.00 | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 61.1 | 60.4 | +0.73 | ULS | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.08 | 1.08 | 0.00 | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.6x | 23.0x | +20.60 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $15.24B | $662.49B | -$647.26B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ULS REV | JNJ REV | ULS GROSS % | JNJ GROSS % | ULS FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $3.05B | $94.19B | 49.5% | 67.9% | $403.0M | $19.70B |
| FY 2024 | $2.87B | $88.82B | 48.5% | 69.1% | $287.0M | $19.84B |
| FY 2023 | $2.68B | $85.16B | 44.0% | 44.0% | $346.5M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ULS // BETA 1.08
JNJ // BETA 1.08